Kathryn Bohannon has been named vice president of biopharmaceutical development at Theorem Clinical Research, and Angela Weston was appointed vice president of business development in Europe and Asia.
 
Ms. Bohannon brings 20 years of R&D experience and medical leadership experience in pediatrics and rare disease, including Phase I-IV clinical research, lab R&D, as well as U.S. and global project management and direct sales and marketing. She has developed and managed projects across multiple therapeutic areas and clinical settings, including the Best Pharmaceuticals for Children Act – Data Coordinating Center within the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Ms. Weston also brings more than 20 years of experience, spanning a range commercial disciplines in the pharmaceutical, biotech and medical device industries. She previously served as senior vice president for business development at a global CRO, where she organized and managed the pharmaceutical, medical device and clinical resource sales teams.
 
“These professionals further enhance our capabilities and client services,” said John Potthoff, Theorem president and chief executive officer. “We have the right experts in place to provide meaningful expertise in key aspects of clinical trials.”